Home Cart 0 Sign in  
X

[ CAS No. 5438-70-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5438-70-0
Chemical Structure| 5438-70-0
Chemical Structure| 5438-70-0
Structure of 5438-70-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5438-70-0 ]

Related Doc. of [ 5438-70-0 ]

Alternatived Products of [ 5438-70-0 ]

Product Details of [ 5438-70-0 ]

CAS No. :5438-70-0 MDL No. :MFCD00017569
Formula : C10H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :CFNDVXUTYPXOPG-UHFFFAOYSA-N
M.W : 179.22 Pubchem ID :225219
Synonyms :

Calculated chemistry of [ 5438-70-0 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 51.52
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.67
Log Po/w (XLOGP3) : 1.6
Log Po/w (WLOGP) : 1.38
Log Po/w (MLOGP) : 1.67
Log Po/w (SILICOS-IT) : 1.67
Consensus Log Po/w : 1.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.04
Solubility : 1.65 mg/ml ; 0.00919 mol/l
Class : Soluble
Log S (Ali) : -2.31
Solubility : 0.877 mg/ml ; 0.0049 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.92
Solubility : 0.214 mg/ml ; 0.00119 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.46

Safety of [ 5438-70-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5438-70-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5438-70-0 ]
  • Downstream synthetic route of [ 5438-70-0 ]

[ 5438-70-0 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 5438-70-0 ]
  • [ 104-10-9 ]
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 6, p. 2598 - 2600
  • 2
  • [ 5438-70-0 ]
  • [ 587-88-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2018, vol. 57, # 31, p. 9896 - 9900[2] Angew. Chem., 2018, vol. 130, p. 10044 - 10048,5
  • 3
  • [ 5438-70-0 ]
  • [ 30132-15-1 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1978, vol. 16, p. 605 - 609
  • 4
  • [ 5438-70-0 ]
  • [ 63610-08-2 ]
Reference: [1] Patent: KR101778331, 2017, B1,
  • 5
  • [ 5438-70-0 ]
  • [ 1197-55-3 ]
Reference: [1] Chemische Berichte, 1939, vol. 72, p. 839,847
  • 6
  • [ 5438-70-0 ]
  • [ 17138-28-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 10, p. 3424 - 3445
  • 7
  • [ 5445-26-1 ]
  • [ 5438-70-0 ]
YieldReaction ConditionsOperation in experiment
100% With palladium 10% on activated carbon; hydrogen In methanol for 4 h; A solution of ethyl 2-(4-nitrophenyl)acetate (3j) (1.05 g, 3.40 mmol) inMeOH (25 mL) was hydrogenated over 10percent Pd/C (catalytic amount) for 4h. The catalyst was filtered off and the resultingsolution was concentrated to afford ethyl 2-(4-aminophenyl)acetate (4j). 1H-NMR 200 MHz (CDCl3) δ: 1.29 (t, 3H, J=7.2Hz ), 3.72 (s, 2H), 4.13 (q, 2H, J=7.2 Hz), 6.51 (d, 2H, J= 7.2 Hz), 6.98 (d, 2H, J= 7.2 Hz). Quantitative yield
97% With palladium on activated charcoal; hydrogen In methanol at 20℃; for 1.5 h; Step 1: Ethyl 2- (4-aminophenyl) acetate[1974]To a solution of ethyl 4-nitrophenylacetate (500 mg, 2.39 mmol) in methanol (10 mL) was added Pd/C (64 mg) . The mixture was stirred at rt for 1.5 hours under hydrogen atomosphere. The mixture was filtered and the filtrate was concentrated to give ethyl 2- (4-aminophenyl) acetate as reddish liquid (420 mg, 97) .[1975]1H NMR (400 MHz, CD3OD) : δ ppm 7.03 (d, J 8.4 Hz, 2H) , 6.71 (d, J 8.4 Hz, 2H) , 4.13 (q, J 7.1 Hz, 1H) , 3.49 (s, 2H) , 1.24 (t, J 7.1 Hz, 3H) and MS-ESI: m/z 180.2 [M+H]+.
Reference: [1] Patent: EP3381898, 2018, A1, . Location in patent: Paragraph 0200; 0272
[2] Patent: WO2015/161830, 2015, A1, . Location in patent: Paragraph 00698
[3] Journal of the American Chemical Society, 2011, vol. 133, # 32, p. 12875 - 12879
[4] Chemical Communications, 2013, vol. 49, # 80, p. 9089 - 9091
[5] ChemCatChem, 2016, vol. 8, # 14, p. 2351 - 2355
[6] Farmaco, 1993, vol. 48, # 4, p. 487 - 501
[7] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 8092 - 8105
[8] Journal of the Chemical Society, 1917, vol. 111, p. 170
[9] Chem. Penicillin, <Princeton 1949>, S. 106, 139,
[10] Chemische Berichte, 1939, vol. 72, p. 839,847
[11] Chemische Berichte, 1934, vol. 67, p. 245
[12] Patent: US6150373, 2000, A,
[13] Patent: US5070087, 1991, A,
[14] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9199 - 9221
[15] ChemMedChem, 2018, vol. 13, # 1, p. 30 - 36
  • 8
  • [ 64-17-5 ]
  • [ 1197-55-3 ]
  • [ 5438-70-0 ]
Reference: [1] Synthesis, 2001, # 14, p. 2143 - 2155
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, p. 2801 - 2807
[3] European Journal of Pharmaceutical Sciences, 2006, vol. 27, # 2-3, p. 188 - 193
[4] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 284 - 297
[5] Steroids, 2017, vol. 123, p. 73 - 83
  • 9
  • [ 1197-55-3 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the American Chemical Society, 1991, vol. 113, # 1, p. 291 - 297
[2] Patent: US4670421, 1987, A,
[3] Patent: US4720506, 1988, A,
[4] Patent: US4205085, 1980, A,
  • 10
  • [ 88975-34-2 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the American Chemical Society, 1991, vol. 113, # 1, p. 291 - 297
  • 11
  • [ 13475-17-7 ]
  • [ 5438-70-0 ]
Reference: [1] European Journal of Organic Chemistry, 2018, vol. 2018, # 23, p. 2995 - 3000
  • 12
  • [ 113180-63-5 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the American Chemical Society, 1991, vol. 113, # 1, p. 291 - 297
  • 13
  • [ 105113-62-0 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the American Chemical Society, 1991, vol. 113, # 1, p. 291 - 297
  • 14
  • [ 123-30-8 ]
  • [ 5438-70-0 ]
Reference: [1] Patent: US4439448, 1984, A,
  • 15
  • [ 104-03-0 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9199 - 9221
[2] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 284 - 297
[3] ChemMedChem, 2018, vol. 13, # 1, p. 30 - 36
  • 16
  • [ 5044-24-6 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, p. 2801 - 2807
  • 17
  • [ 26165-63-9 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, p. 2801 - 2807
  • 18
  • [ 95337-70-5 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, p. 2801 - 2807
  • 19
  • [ 83756-25-6 ]
  • [ 5438-70-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1984, p. 2801 - 2807
  • 20
  • [ 555-21-5 ]
  • [ 5438-70-0 ]
Reference: [1] Chemische Berichte, 1939, vol. 72, p. 839,847
[2] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 284 - 297
  • 21
  • [ 140-29-4 ]
  • [ 5438-70-0 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 284 - 297
  • 22
  • [ 5438-70-0 ]
  • [ 56205-88-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2647 - 2652
[2] Patent: US2014/142081, 2014, A1,
[3] Patent: WO2014/79136, 2014, A1,
[4] Patent: WO2014/79150, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5438-70-0 ]

Aryls

Chemical Structure| 52273-79-7

[ 52273-79-7 ]

Ethyl 2-(3-aminophenyl)acetate

Similarity: 0.98

Chemical Structure| 174579-31-8

[ 174579-31-8 ]

tert-Butyl 2-(4-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 52913-11-8

[ 52913-11-8 ]

Methyl 2-(3-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 850449-93-3

[ 850449-93-3 ]

Methyl 2-(5-amino-2-methylphenyl)acetate

Similarity: 0.94

Chemical Structure| 35613-44-6

[ 35613-44-6 ]

Methyl 2-(2-aminophenyl)acetate

Similarity: 0.92

Esters

Chemical Structure| 52273-79-7

[ 52273-79-7 ]

Ethyl 2-(3-aminophenyl)acetate

Similarity: 0.98

Chemical Structure| 174579-31-8

[ 174579-31-8 ]

tert-Butyl 2-(4-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 52913-11-8

[ 52913-11-8 ]

Methyl 2-(3-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 850449-93-3

[ 850449-93-3 ]

Methyl 2-(5-amino-2-methylphenyl)acetate

Similarity: 0.94

Chemical Structure| 35613-44-6

[ 35613-44-6 ]

Methyl 2-(2-aminophenyl)acetate

Similarity: 0.92

Amines

Chemical Structure| 52273-79-7

[ 52273-79-7 ]

Ethyl 2-(3-aminophenyl)acetate

Similarity: 0.98

Chemical Structure| 174579-31-8

[ 174579-31-8 ]

tert-Butyl 2-(4-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 52913-11-8

[ 52913-11-8 ]

Methyl 2-(3-aminophenyl)acetate

Similarity: 0.94

Chemical Structure| 850449-93-3

[ 850449-93-3 ]

Methyl 2-(5-amino-2-methylphenyl)acetate

Similarity: 0.94

Chemical Structure| 35613-44-6

[ 35613-44-6 ]

Methyl 2-(2-aminophenyl)acetate

Similarity: 0.92